Clinical Trial Update: Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics and safety of bosutinib in subjects with liver disease and in healthy controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chronic Myeloid Leukemia

Drugs mentioned

• BOSULIF (bosutinib)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Breast Cancer, Leukemia, Myeloid, Chronic | Phase 1 | Status: COMPLETED